Thomas B Smith Collegium Pharmaceutical, Inc (COLL) insider trading activity

Thomas B Smith is EVP and Chief Medical Officer of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 87,742 shares of COLL, which is worth approximately $2.6 Million. The most recent transaction as insider was on Feb 10, 2025, when has been sold 5,897 shares (Common Stock) at a price of $30.52 per share, resulting in proceeds of $179,976. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.7K

63.04% 3M change

36.24% 12M change

Total Value Held $2.6 Million

Thomas B Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2025	SELL Payment of exercise price or tax liability	$179,976 $30.52 p/Share	5,897 Reduced 6.3%	87,742 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	39,075 Added 29.44%	93,639 Common Stock
Sep 13 2024	SELL Open market or private sale	$351,295 $36.62 p/Share	9,593 Reduced 15.13%	53,816 Common Stock
Feb 29 2024	SELL Open market or private sale	$36,576 $36.76 p/Share	995 Reduced 1.54%	63,409 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$107,806 $33.7 p/Share	3,199 Reduced 4.73%	64,404 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	35,423 Added 34.38%	67,603 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	31,185 Added 50.0%	31,185 Common Stock

Also insider at

BDSI

BIODELIVERY SCIENCES INTERNATIONAL INC Healthcare

Chief Medical Officer

TBS

Thomas B Smith

EVP and Chief Medical Officer

Raleigh, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Value

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

Operation

Value

Type

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL

Account